Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 16/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.34 |
| ▸ | FPR2 | P25090 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12185783 | 1.00 | GPR119 (0.43) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL2597223 | 0.90 | GPR119 (0.42) | GPR119CYP3A4CYP2C9KCNH2SLC6A9 | |
| SCHEMBL15022888 | 0.90 | GPR119 (0.42) | GPR119CYP3A4CYP2C9KCNH2SLC6A9 | |
| SCHEMBL2599393 | 0.90 | GPR119 (0.43) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL15022641 | 0.90 | GPR119 (0.43) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL12186171 | 0.90 | GPR119 (0.43) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL15023343 | 0.89 | TIPARP (0.44) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL12185781 | 0.89 | TIPARP (0.44) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL15022739 | 0.89 | GPR119 (0.56) | GPR119CYP3A4CYP2C9CCNA2CDK2 | |
| SCHEMBL15022738 | 0.89 | GPR119 (0.56) | GPR119CYP3A4CYP2C9CCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8754226-B2 | Piperidinyl-substituted lactams as GPR119 modulators | ARRAY BIOPHARMA INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20130158009-A1 | PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS | ARRAY BIOPHARMA, INC. | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158009-A1 | PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS | GPR119, GPR139, GPR39 | GPR119 1/4885CYP3A4 2459/4885CYP2C9 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.